Aspirin and novel oral anticoagulants : reporting of adverse drug reactions

Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/51113

Title:	Aspirin and novel oral anticoagulants : reporting of adverse drug reactions
Authors:	Attard, Jessica Vella Szijj, Janis Serracino-Inglott, Anthony
Keywords:	Aspirin -- Side effects Rivaroxaban -- Side effects Anticoagulants (Medicine) -- Side effects Drugs -- Side effects -- Reporting
Issue Date:	2018-11
Publisher:	University of Malta. Department of Pharmacy
Citation:	Attard, J., Vella Szijj, J., & Serracino-Inglott, A. (2018, November). Aspirin and novel oral anticoagulants: reporting of adverse drug reactions. Poster session presented at the X Malta Medical School Conference, St Julian's, Malta.
Abstract:	A poster presentation regarding aspirin and novel oral anticoagulants: reporting of adverse drug reactions. Introduction: Adverse drug reactions (ADRs) result in approximately 200,000 deaths per year and contribute to about 5% of all hospital admissions, in Europe. The efficacy of antithrombotic medications such as aspirin may vary between patients and alternative medications need to be identified. Novel oral anticoagulants (NOACs) provide alternative options for thromboprophylaxis. Aims: • To conduct a comparative analysis of ADRs reported for aspirin and ADRs reported for the NOACs as documented in pharmacovigilance (PV) reports. • To observe ADRs following the use of aspirin and NOACs in the Maltese population and compare them to ADRs from PV reports. • To identify studies on the use of NOACs in PAD. • To analyse consumption trends for NOACs.
URI:	https://www.um.edu.mt/library/oar/handle/123456789/51113
Appears in Collections:	Scholarly Works - FacM&SPha

Files in This Item:

File	Description	Size	Format
Aspirin_and_novel_oral_anticoagulants_reporting_of_adverse_drug_reactions_2018.pdf		478.4 kB	Adobe PDF	View/Open

Show full item record Statistics